Ocular melanoma MDT discuss FOCUS trial and NICE 2021 guidance.

3 Pogledi
administrator
administrator
07/30/23

Update on new NICE guidance - DELCATH, php, chemosat - for use in ocular melanoma and discussion around funding / upcoming FOCUS trial data.

  • Kategorija

Prikaži više

0 Komentari Poredaj po

Nema komentara

Komentari na Facebooku

Sljedeći